Johan Lund

2.6k total citations
70 papers, 1.9k citations indexed

About

Johan Lund is a scholar working on Molecular Biology, Health, Toxicology and Mutagenesis and Genetics. According to data from OpenAlex, Johan Lund has authored 70 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 14 papers in Health, Toxicology and Mutagenesis and 13 papers in Genetics. Recurrent topics in Johan Lund's work include Estrogen and related hormone effects (13 papers), Toxic Organic Pollutants Impact (12 papers) and Multiple Myeloma Research and Treatments (11 papers). Johan Lund is often cited by papers focused on Estrogen and related hormone effects (13 papers), Toxic Organic Pollutants Impact (12 papers) and Multiple Myeloma Research and Treatments (11 papers). Johan Lund collaborates with scholars based in Sweden, Norway and United States. Johan Lund's co-authors include L. E. Aaro, Marit Bakke, Anne L. Jacob, Jan-Ακε Gustafsson, Olof Andersson, Björn Brunström, Bert‐Ove Lund, Lorenz Poellinger, Ronan A Lyons and Hareth Nahi and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Biochemistry.

In The Last Decade

Johan Lund

69 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Johan Lund Sweden 25 542 365 281 264 194 70 1.9k
Patrick J. Ward United States 21 424 0.8× 213 0.6× 144 0.5× 84 0.3× 113 0.6× 67 2.0k
John C. Chambers United Kingdom 26 730 1.3× 650 1.8× 143 0.5× 73 0.3× 208 1.1× 78 2.8k
Lauren R. Teras United States 27 469 0.9× 227 0.6× 158 0.6× 172 0.7× 402 2.1× 89 2.7k
C. C. Brown United States 20 302 0.6× 244 0.7× 133 0.5× 138 0.5× 401 2.1× 28 1.8k
Ingrid Nordenson Sweden 27 790 1.5× 379 1.0× 121 0.4× 459 1.7× 210 1.1× 77 2.2k
Ellen F. Heineman United States 31 427 0.8× 130 0.4× 899 3.2× 627 2.4× 704 3.6× 49 3.2k
William Wheeler United States 21 498 0.9× 372 1.0× 142 0.5× 179 0.7× 100 0.5× 51 1.7k
Guangyuan Hu China 20 421 0.8× 56 0.2× 198 0.7× 77 0.3× 214 1.1× 82 1.5k
Carolina Espina France 24 531 1.0× 138 0.4× 134 0.5× 124 0.5× 268 1.4× 73 1.9k
Pierluigi Cocco Italy 27 303 0.6× 235 0.6× 526 1.9× 408 1.5× 426 2.2× 99 2.5k

Countries citing papers authored by Johan Lund

Since Specialization
Citations

This map shows the geographic impact of Johan Lund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johan Lund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johan Lund more than expected).

Fields of papers citing papers by Johan Lund

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johan Lund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johan Lund. The network helps show where Johan Lund may publish in the future.

Co-authorship network of co-authors of Johan Lund

This figure shows the co-authorship network connecting the top 25 collaborators of Johan Lund. A scholar is included among the top collaborators of Johan Lund based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johan Lund. Johan Lund is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Uttervall, Katarina, Göran Wålinder, Robert Månsson, et al.. (2019). Upfront bortezomib, lenalidomide, and dexamethasone compared to bortezomib, cyclophosphamide, and dexamethasone in multiple myeloma. European Journal Of Haematology. 103(3). 247–254. 7 indexed citations
3.
Nahi, Hareth, Michael Chrobok, Johan Lund, et al.. (2019). Infectious complications and NK cell depletion following daratumumab treatment of Multiple Myeloma. PLoS ONE. 14(2). e0211927–e0211927. 75 indexed citations
4.
Duru, Adil Doganay, Tolga Sütlü, Katarina Uttervall, et al.. (2015). Deletion of Chromosomal Region 8p21 Confers Resistance to Bortezomib and Is Associated with Upregulated Decoy TRAIL Receptor Expression in Patients with Multiple Myeloma. PLoS ONE. 10(9). e0138248–e0138248. 6 indexed citations
5.
Lund, Johan, Katarina Uttervall, Johan Liwing, et al.. (2013). Addition of thalidomide to melphalan and prednisone treatment prolongs survival in multiple myeloma – a retrospective population based study of 1162 patients. European Journal Of Haematology. 92(1). 19–25. 4 indexed citations
6.
Kudryavtsev, Alexander V., Odd Nilssen, Johan Lund, A M Grjibovski, & Børge Ytterstad. (2012). Road traffic crashes with fatal and non-fatal injuries in Arkhangelsk, Russia in 2005–2010. International Journal of Injury Control and Safety Promotion. 20(4). 349–357. 15 indexed citations
7.
Wergeland, Ebba, Finn Gjertsen, & Johan Lund. (2009). Arbeidsskadedødsfall blir underrapportert. Tidsskrift for Den norske legeforening. 129(10). 981–986. 3 indexed citations
8.
Gravseth, Hans Magne, Johan Lund, & Ebba Wergeland. (2006). Risikofaktorer for ulykkesskader i bygge- og anleggsbransjen. Tidsskrift for Den Norske Laegeforening. 2 indexed citations
9.
Pierrou, Stefan, Per Broberg, Rory O’Donnell, et al.. (2006). Expression of Genes Involved in Oxidative Stress Responses in Airway Epithelial Cells of Smokers with Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 175(6). 577–586. 169 indexed citations
10.
Tellnes, Gunnar, Johan Lund, Leiv Sandvik, Elise Klouman, & Børge Ytterstad. (2006). Long-term effects of community-based injury prevention on the island of Værøy in Norway: A 20-year follow up. Scandinavian Journal of Social Medicine. 34(3). 312–319. 7 indexed citations
11.
Gravseth, Hans Magne, Johan Lund, & Ebba Wergeland. (2003). [Occupational injuries in Oslo: a study of occupational injuries treated by the Oslo Emergency Ward and Oslo Ambulance Service].. PubMed. 123(15). 2060–4. 6 indexed citations
12.
Gravseth, Hans Magne, Ebba Wergeland, & Johan Lund. (2003). Underrapportering av arbeidsskader til Arbeidstilsynet. Tidsskrift for Den Norske Laegeforening. 6 indexed citations
13.
Gravseth, Hans Magne, Johan Lund, & Ebba Wergeland. (2003). Arbeidsskader behandlet ved Legevakten i Oslo og Ambulansetjenesten. Tidsskrift for Den Norske Laegeforening. 3 indexed citations
14.
Ytterstad, Børge & Johan Lund. (2000). Forebygging av barneulykker i Norge. Tidsskrift for Den Norske Laegeforening. 1 indexed citations
15.
Jacob, Anne L. & Johan Lund. (1998). Mutations in the Activation Function-2 Core Domain of Steroidogenic Factor-1 Dominantly Suppresses PKA-dependent Transactivation of the Bovine CYP17 Gene. Journal of Biological Chemistry. 273(22). 13391–13394. 39 indexed citations
16.
Lund, Johan, Peter G. Zaphiropoulos, Agneta Mode, Margaret Warner, & Jan-Åke Gustafsson. (1991). Hormonal Regulation of Cytochrome P-450 Gene Expression. Advances in pharmacology. 22. 325–354. 27 indexed citations
17.
18.
Kurl, Rabinder N., Johan Lund, Mikael Gillner, et al.. (1982). High-affinity binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin in cell nuclei from rat liver. Biochimica et Biophysica Acta (BBA) - General Subjects. 714(3). 516–523. 28 indexed citations
19.
Dissing, J., Johan Lund, & Henrik Toft Sørensen. (1972). C3 Polymorphism in a Group of Old Arteriosclerotic Patients. Human Heredity. 22(5-6). 466–472. 20 indexed citations
20.
Lund, Johan. (1967). Biologically active metabolites of vitamin D.. 28. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patrick J. Ward Breakdown of academic impact, for papers by John C. Chambers Breakdown of academic impact, for papers by Lauren R. Teras Breakdown of academic impact, for papers by C. C. Brown Breakdown of academic impact, for papers by Ingrid Nordenson Breakdown of academic impact, for papers by Ellen F. Heineman Breakdown of academic impact, for papers by William Wheeler Breakdown of academic impact, for papers by Guangyuan Hu Breakdown of academic impact, for papers by Carolina Espina Breakdown of academic impact, for papers by Pierluigi Cocco
Rankless by CCL
2026